These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9255178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
    Spence AM, Muzi M, Graham MM, O'Sullivan F, Krohn KA, Link JM, Lewellen TK, Lewellen B, Freeman SD, Berger MS, Ojemann GA.
    J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
    [Abstract] [Full Text] [Related]

  • 4. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y, Konishi J, Makada Y, Yonekura Y.
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Functional brain study by radionuclide neuroimaging].
    Uemura K.
    No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
    [No Abstract] [Full Text] [Related]

  • 7. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
    Tamminga CA.
    Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
    [No Abstract] [Full Text] [Related]

  • 8. Functional brain imaging in 200 patients after whiplash injury.
    Otte A, Mueller-Brand J, Nitzsche EU, Wachter K, Ettlin TM.
    J Nucl Med; 1997 Jun; 38(6):1002. PubMed ID: 9189162
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y, Kato T, Tadokoro M, Sobue G.
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
    Cinotti L, Croisile B, Laurent B, Le Bars D, Malbezin M, Mauguière F.
    Eur Neurol; 1995 Jan; 35 Suppl 1():17-22. PubMed ID: 8529724
    [No Abstract] [Full Text] [Related]

  • 13. Emission computed tomography in the study of human epilepsy.
    Kuhl DE, Engel J, Phelps ME.
    Res Publ Assoc Res Nerv Ment Dis; 1983 Jan; 61():327-40. PubMed ID: 6601815
    [No Abstract] [Full Text] [Related]

  • 14. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J, Itoh M, Matsuzawa T.
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuroimaging in epilepsy: is there a future for positron emission tomography.
    Sadzot B.
    Epilepsia; 1996 Jun; 37(6):511-4. PubMed ID: 8641225
    [No Abstract] [Full Text] [Related]

  • 17. Positron emission tomography.
    Cohen RM, Semple WE, Gross M.
    Psychiatr Clin North Am; 1986 Mar; 9(1):63-79. PubMed ID: 3515332
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors.
    Kole AC, Nieweg OE, Hoekstra HJ, van Horn JR, Koops HS, Vaalburg W.
    J Nucl Med; 1998 May; 39(5):810-5. PubMed ID: 9591581
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.